Feedback Mechanism Between Blood Vessels and Astrocytes in Retinal Vascular development

Trends in Cardiovascular Medicine

Volumn 19, Issue 2, 2009, Pages 38-43

  Kubota, Yoshiaki ^a   Suda, Toshio ^a  

^a Institute for Advanced Medical Research   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; LEUKEMIA INHIBITORY FACTOR; OXYGEN; VASCULOTROPIN;

ANGIOGENESIS; ASTROCYTE; CELL INTERACTION; DRUG TARGETING; ENDOTHELIUM CELL; EYE CANCER; EYE DISEASE; FEEDBACK SYSTEM; HUMAN; NEGATIVE FEEDBACK; NERVE CELL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; RETINA BLOOD VESSEL; RETINA NEOVASCULARIZATION; REVIEW;

ANGIOGENESIS INHIBITORS; ANIMALS; ASTROCYTES; CELL COMMUNICATION; CELL HYPOXIA; ENDOTHELIAL CELLS; FEEDBACK, BIOCHEMICAL; HUMANS; LEUKEMIA INHIBITORY FACTOR; NEOVASCULARIZATION, PHYSIOLOGIC; OXYGEN; RETINAL GANGLION CELLS; RETINAL NEOVASCULARIZATION; RETINAL VESSELS; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 67649432940     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tcm.2009.04.004     Document Type: Review

References (41)

1. Ash J., McLeod D.S., and Lutty G.A. Transgenic expression of leukemia inhibitory factor (LIF) blocks normal vascular development but not pathological neovascularization in the eye. Mol Vis 11 (2005) 298-308
2. Ashton N. Retinal angiogenesis in the human embryo. Br Med Bull 26 (1970) 103-106
3. Bozec A., Bakiri L., Hoebertz A., et al. Osteoclast size is controlled by Fra-2 through LIF/LIF-receptor signalling and hypoxia. Nature 454 (2008) 221-225
4. Carmeliet P. Angiogenesis in health and disease. Nat Med 9 (2003) 653-660
5. Carmeliet P. Angiogenesis in life, disease and medicine. Nature 438 (2005) 932-936
6. Fruttiger M. Development of the mouse retinal vasculature: angiogenesis versus vasculogenesis. Invest Ophthalmol Vis Sci 43 (2002) 522-527
7. Fruttiger M., Calver A.R., and Kruger W.H. PDGF mediates a neuron-astrocyte interaction in the developing retina. Neuron 17 (1996) 1117-1131
8. Fruttiger M., Calver A.R., and Richardson W.D. Platelet derived growth factor is constitutively secreted from neuronal cell bodies but not from axons. Curr Biol 10 (2000) 1283-1286
9. Gariano R.F., and Gardner T.W. Retinal angiogenesis in development and disease. Nature 438 (2005) 960-966
10. Gearing D.P., Gough N.M., King J.A., et al. Molecular cloning and expression of cDNA encoding a murine myeloid leukaemia inhibitory factor (LIF). EMBO J 6 (1987) 3995-4002
11. Gerhardt H., Golding M., Fruttiger M., et al. VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia. J Cell Biol 161 (2003) 1163-1177
12. Gough N.M., Williams R.L., Hilton D.J., et al. LIF: a molecule with divergent actions on myeloid leukaemic cells and embryonic stem cells. Reprod Fertil Dev 1 (1989) 281-288
13. Hasegawa T., McLeod D.S., Prow T., et al. Vascular precursors in developing human retina. Invest Ophthalmol Vis Sci 49 (2008) 2178-2192
14. Hellström M., Phng L.K., Hofmann J.J., et al. Dll4 signalling through Notch1 regulates formation of tip cells during angiogenesis. Nature 445 (2007) 776-780
15. Jacque C.M., Kujas M., Poreau A., et al. GFA and S 100 protein levels as an index for malignancy in human gliomas and neurinomas. J Natl Cancer Inst 62 (1979) 479-483
16. Jeong C.H., Lee H.J., Cha J.H., et al. Hypoxia-inducible factor-1 alpha inhibits self-renewal of mouse embryonic stem cells in Vitro via negative regulation of the leukemia inhibitory factor-STAT3 pathway. J Biol Chem 282 (2007) 13672-13679
17. Koblar S.A., Turnley A.M., Classon B.J., et al. Neural precursor differentiation into astrocytes requires signaling through the leukemia inhibitory factor receptor. Proc Natl Acad Sci U S A 95 (1998) 3178-3181
18. Kubota Y., Hirashima M., Kishi K., et al. Leukemia inhibitory factor regulates microvessel density by modulating oxygen-dependent VEGF expression in mice. J Clin Invest 118 (2008) 2393-2403
19. Land S.C., and Tee A.R. Hypoxia-inducible factor 1alpha is regulated by the mammalian target of rapamycin (mTOR) via an mTOR signaling motif. J Biol Chem 282 (2007) 20534-20543
20. Lee J.W., Bae S.H., Jeong J.W., et al. Hypoxia-inducible factor (HIF-1) alpha: its protein stability and biological functions. Exp Mol Med 36 (2004) 1-12
21. Lobov I.B., Renard R.A., Papadopoulos N., et al. Delta-like ligand 4 (Dll4) is induced by VEGF as a negative regulator of angiogenic sprouting. Proc Natl Acad Sci USA 104 (2007) 3219-3224
22. Mi H., Haeberle H., and Barres B.A. Induction of astrocyte differentiation by endothelial cells. J Neurosci 21 (2001) 1538-1547
23. Mukouyama Y.S., Shin D., Britsch S., et al. Sensory nerves determine the pattern of arterial differentiation and blood vessel branching in the skin. Cell 109 (2002) 693-705
24. Nakashima K., Wiese S., Yanagisawa M., et al. Developmental requirement of gp130 signaling in neuronal survival and astrocyte differentiation. J Neurosci 19 (1999) 5429-5434
25. Ng Y.S., Rohan R., Sunday M.E., et al. Differential expression of VEGF isoforms in mouse during development and in the adult. Dev Dyn 220 (2001) 112-121
26. Noguera-Troise I., Daly C., Papadopoulos N.J., et al. Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis. Nature 444 (2006) 1032-1037
27. Pepper M.S., Ferrara N., Orci L., and Montesano R. LIF in vitro leukemia inhibitory factor (LIF) inhibits angiogenesis in vitro. J Cell Sci 108 (1995) 73-83
28. Ruhrberg C., Gerhardt H., Golding M., et al. Spatially restricted patterning cues provided by heparin-binding VEGF-A control blood vessel branching morphogenesis. Genes Dev 16 (2002) 2684-2698
29. Semenza G.L., Agani F., Iyer N., et al. Regulation of cardiovascular development and physiology by hypoxia-inducible factor 1. Ann N Y Acad Sci 874 (1999) 262-268
30. Smith L.E., Wesolowski E., McLellan A., et al. Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci 35 (1994) 101-111
31. Stewart C.L., Kaspar P., Brunet L.J., et al. Blastocyst implantation depends on maternal expression of leukaemia inhibitory factor. Nature 359 (1992) 76-79
32. Suchting S., Freitas C., le Noble F., et al. The Notch ligand delta-like 4 negatively regulates endothelial tip cell formation and vessel branching. Proc Natl Acad Sci U S A 104 (2007) 3225-3230
33. Taga T., and Kishimoto T. Gp130 and the interleukin-6 family of cytokines. Annu Rev Immunol 15 (1997) 797-819
34. Tse V., Xu L., Yung Y.C., et al. The temporal-spatial expression of VEGF, angiopoietins-1 and 2, and Tie-2 during tumor angiogenesis and their functional correlation with tumor neovascular architecture. Neurol Res 25 (2003) 729-738
35. Uemura A., Kusuhara S., Wiegand S.J., et al. Tlx acts as a proangiogenic switch by regulating extracellular assembly of fibronectin matrices in retinal astrocytes. J Clin Invest 116 (2006) 369-377
36. Vinores S.A., Xiao W.H., Aslam S., et al. Implication of the hypoxia response element of the Vegf promoter in mouse models of retinal and choroidal neovascularization, but not retinal vascular development. J Cell Physiol 206 (2006) 749-758
37. Wakitani S., Hondo E., Shimokawa T., et al. Effects of leukemia inhibitory factor on lectin-binding patterns in the uterine stromal vessels of mice. Immunobiology 213 (2008) 143-150
38. Ware C.B., Horowitz M.C., Renshaw B.R., et al. Targeted disruption of the low-affinity LIF receptor gene causes placental, skeletal, neural and metabolic defects and results in perinatal death. Development 121 (1995) 1283-1299
39. Weber M.A., Schnyder-Candrian S., Schnyder B., et al. Endogenous leukemia inhibitory factor attenuates endotoxin response. Lab Invest 85 (2005) 276-284
40. West H., Richardson W.D., and Fruttiger M. Stabilization of the retinal vascular network by reciprocal feedback between blood vessels and astrocytes. Development 132 (2005) 1855-1862
41. Yamaguchi T.P., Dumont D.J., Conlon R.A., et al. flk-1, an flt-related receptor tyrosine kinase is an early marker for endothelial cell precursors. Development 118 (1993) 489-498